Dear Well-wishers, I am pleased to meet you through this March 2023 edition of Oviya MedSafe‘s newsletter (the 124th in the series since April 2012) in which I intend to outline some practical challenges faced by fast-growing multinational pharma/biotech/healthcare companies when they begin to constitute an integrated global Pharmacovigilance system aimed at attaining total regulatory […]
Dear Well-wishers, Much more than ever before, I am delighted to greet you through this February 2023 edition of Oviya MedSafe‘s newsletter (the 123rd in the series since April 2012) that is being released soon after the 11th anniversary of Oviya MedSafe’s founding (on 14th March)! On this occasion, let me thank each one of […]
Dear Well-wishers, It is my utmost pleasure to connect with you through this January 2023 edition of Oviya MedSafe‘s newsletter (the 122nd in the series since April 2012) which aspires to underline the true essence of professionalism in the context of providing Pharmacovigilance services and takes pride in proclaiming how Oviya MedSafe resolutely stands tall […]
As we move into 2023, all of us at Oviya MedSafe take the pleasure of wishing you and your loved ones a very Happy & Prosperous New Year 2023 through this December 2022 edition of Oviya MedSafe’s newsletter
Dear Well-wishers, I begin writing this November 2022 edition of Oviya MedSafe‘s newsletter (the 120th in the series since April 2012) with a thankful smile, thinking of the heartfelt appreciation we received from many of you in response to last month’s edition in which I spoke about how Oviya MedSafe’s unique QPPV office support has […]
Dear Well-wishers, I am pleased to meet you all through this October 2022 edition of Oviya MedSafe‘s newsletter (the 119th in the series since April 2012) in which I intend to present the next “Pharmacovigilance Business Pearl” from Oviya MedSafe, following up on the topic I first started a few months ago. Qualified Person for Pharmacovigilance (QPPV) is one term that […]
Dear Well-wishers, I am heartened to connect with you after a gap of 3 months through this July-September 2022 edition of Oviya MedSafe‘s newsletter (the 118th in the series since April 2012). While I was not happy to withhold the monthly stream of our newsletters, I had to do so for this brief period in order to get […]
You decided that further development of the project is impossible without search engine promotion. We found a specialist, provided him with access…
You decided that further development of the project is impossible without search engine promotion. We found a specialist, provided him with access…
You decided that further development of the project is impossible without search engine promotion. We found a specialist, provided him with access…